Progression-free survival with first line treatment as prognostic factor of treatment success in subsequent lines in lung adenocarcinoma patients - who's the,good responder"?
EUROPEAN RESPIRATORY JOURNAL（2021）
关键词
Lung cancer - management, Treatments, Personalised medicine
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要